About Erganeo
Erganeo is a venture capital firm founded in 2012. It is primarily based out of Paris, France. As of Dec 2021, Erganeo has invested in 27 companies. It primarily invests in Seed round in France based startups. Its investments are spread across a wide range of sectors from Life Sciences to HealthTech and High Tech. Most recently it participated in the $***** Seed round of Orixha Overall, Erganeo portfolio has seen 2 acquisitions, namely Open Agora. A lot of funds co-invest with Erganeo, with names like INFIPLAST sharing a substantial percentage of its portfolio. Erganeo has team of 7 people including 1 partners.Key Metrics
Team Members
Portfolio Sectors
Portfolio Locations
Rounds of Entry
Seed & Series A
Portfolio Acquisitions
Erganeo's List of Top Investments
Erganeo has a portfolio of 27 companies. Their most notable investments are in Orixha and Ermium Therapeutics.Their portfolio spans across and France. They have invested in Life Sciences, HealthTech, High Tech and 13 other sectors, across stages such as Seed, Series A stages. Here is the list of top investments by Erganeo:1. EVerZom
EVerZom develops a technology platform for the production of extracellular vesicles. The extracellular vesicles are generated by Mesenchymal stem cells having regenerative properties. This method can be used to apply turbulence stimulation to cells.
Key facts about EVerZom
2. Orixha
Developer of liquid ventilation technology for critical care patient treatment. The system enables controlled hypothermia for patients experiencing post cardiac arrest syndrome. This technology focuses on the rapid cooling of biological systems to improve clinical outcomes. The approach utilizes breathable liquid to stabilize body temperatures during critical care interventions.
Key facts about Orixha
- Founded Year: 2017
- Location: Maisons Alfort (France)
- Stage: Seed
- Total Funding till date: $2.25M
- Employee Count: 15 as on Oct 31, 2026
- Investors: EIC Fund, EIT Health and 3 Others
- Latest Funding Round: Grant (prize money), Jun 2022, $*****
Ermium Therapeutic is developing therapies for auto-immune inflammatory diseases. The leading candidate of the company is CXCR4 which has antagonists action and can regulate the inflammation. The candidate helps in the production of type 1 interferons by plasmacytoid dendritic cells (pDC)for treating inflammatory diseases. The diseases targeted by the candidate are multiple sclerosis, rheumatoid arthritis, inflammatory bowel diseases, and others.
Key facts about Ermium Therapeutics
- Founded Year: 2019
- Location: Paris (France)
- Stage: Series A
- Total Funding till date: $13.3M
- Employee Count: 1 as on Aug 31, 2026
- Investors: Kurma Partners, Fountain Healthcare Partners and 4 Others
- Latest Funding Round: Series A, Jun 30, 2022, $*****
- Highlight: Editors' Pick
Developer of exosome-based therapeutic solutions for gastrointestinal diseases. The company is engaged in the development of cell-free regenerative medicine EVOGEX that helps in treating gastrointestinal fistula that is an abnormal opening in the stomach or intestines that allows the contents to leak & other GI-related indications.
Key facts about Evora Biosciences
- Founded Year: 2020
- Location: France
- Stage: Funding Raised
- Employee Count: 5 as on Oct 31, 2026
- Investors: WeLikeStartup, EIT Health and 2 Others
5. Millidrop
MilliDrop develops benchtop automated instruments that allow handling and analysis of up to 10,000 reactions in parallel. Its first cell culture Machin; MilliDrop Analyzer based on milli fluidics technology for bacteriological research and diagnosis purposes. Its technology has already been validated in microbiology for the screening of algae, fungi, bacteria, and yeasts as well as for antimicrobial susceptibility testings.
Key facts about Millidrop
- Founded Year: 2015
- Location: Paris (France)
- Stage: Seed
- Total Funding till date: $1.13M
- Employee Count: 3 as on May 31, 2026
- Investors: Seventure Partners, EIC Fund and 3 Others
- Latest Funding Round: Conventional Debt, Sep 12, 2018, $*****
Erganeo's Year-on-Year Investment Trends
Erganeo has invested in 27 companies over the last 7 years, with an average of 0 new investment annually in the last 5 years. Its most recent first time investment was in Orixha.Erganeo's Investments by Stage
Erganeo has made 1 investment in Seed stage with an average round size of $2.25M and 1 investment in Series A stage with an average round size of $6.96M.Erganeo's Investments by Sector
Erganeo has a portfolio focused on Life Sciences. Notably, it has invested in 17 Tech companies, 15 Enterprise (B2B) companies, 6 Software companies and at least 3 companies focusing on Tech hardware.Erganeo's Investments by Geography
Erganeo has made most investments in France (2).Erganeo's recent investments
Erganeo has not made any investment in 2026 so far.Here are the most recent investments by Erganeo:
Date | Company | Location | Round Details | Round Amount | Co-Investors |
|---|---|---|---|---|---|
Dec 10, 2021 | France | Seed | 2481 | ||
Sep 11, 2019 | France | Series A | 3746 | [+3] |
Acquired companies in Erganeo's Portfolio
2 companies from Erganeo's portfolio have been acquired. The most recent acquisition was Open Agora in Sep 2020 by Jamespot for $*****.Here are Erganeo's portfolio companies that got acquired most recently:
Company | Acquisition Date | First Invested on | First Round of Investment | Round Size |
|---|---|---|---|---|
Sep 22, 2020 | - | - | 1642 | |
Apr 22, 2020 | - | - | 5700 |
Team profile of Erganeo
Erganeo has a team of 7 members including 1 Partner and 1 Principal located in France. Erganeo's team does not sit on the board of any company as of now.Co-investors of Erganeo
Over the past 7 years, 8 investors have co-invested in Erganeo's portfolio companies. This includes only funds.
- Invested before Erganeo: EIT Health has invested before Erganeo.
- Top Co-investors of Erganeo: 5 investors entered a company along with Erganeo. These include investors like INFIPLAST (1 company).
- Invested after Erganeo: EIC Fund (1 company) and Fountain Healthcare Partners (1 company) are the investors which have invested in Erganeo's portfolio after their investments.
Recent News related to Erganeo
•
•


